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Abstract: Transcranial direct current stimulation of the cerebellum (c-tDCS) improves motor
performance in young and old adults. Based on the cerebellar involvement in Parkinson’s disease (PD),
c-tDCS could have potential to improve motor function in PD. The purpose was to determine the effects
of c-tDCS on motor performance in PD while participants were on medications. The study was a
randomized, double-blind, SHAM-controlled, between-subjects design. Twenty-two participants
with PD were allocated to either a c-tDCS group or a SHAM group. All participants completed one
experimental session and performed two motor tasks with their most affected hand in a Baseline
condition (no stimulation) and an Experimental condition. The motor tasks were a visuomotor
isometric precision grip task (PGT) and a rapid arm movement task (AMT). The primary dependent
variables were force error and endpoint error in the PGT and AMT, respectively. There were
no significant differences in force error or endpoint error in the Experimental condition between
the c-tDCS and SHAM groups. These results indicate that an acute application of c-tDCS does not
enhance motor performance in hand and arm tasks in PD. Longer-term c-tDCS application over
multiple days may be needed to enhance motor function in PD.
Keywords: Parkinson’s disease; transcranial direct current stimulation; motor skill; cerebellum;
cerebellar stimulation
1. Introduction
Parkinson’s disease (PD) is a progressive, neurodegenerative disorder that is characterized
by debilitating motor symptoms including tremor, rigidity, postural instability, and bradykinesia.
The current pharmaceutical, surgical, and other management strategies for PD are directed towards
relieving the symptoms associated with the disease. Levodopa, often combined with other medications
represents the standard treatment for PD, but their efficacy diminishes over time [1] and leads to side
effects such as dyskinesia. For advanced PD, advanced treatments such as deep brain stimulation are
often considered and can substantially improve motor performance and quality of life [2]. However,
deep brain stimulation is associated with surgical contraindications, high costs, neuropsychiatric
side effects, and is not effective in treating non-motor PD symptoms [3]. Physical exercise is also
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commonly prescribed in PD primarily based on animal studies [4,5], and literature reviews have
concluded that exercise is mild to moderately effective in improving many aspects of motor function in
PD [6,7]. While several forms of exercise [8,9] can induce clinically significant motor improvements in
PD, the most successful strategy to improve motor function would likely entail pairing adjunctive
therapies with rehabilitation to enhance or complement the effects of existing treatments. Transcranial
direct current stimulation (tDCS) is a form of non-invasive brain stimulation that when applied
to the primary motor cortex (M1-tDCS) has shown the ability to increase cortical excitability and
improve motor performance in healthy adults [10] and in PD [11]. These positive effects on motor
performance are thought to be mediated by the changes in excitability in acute conditions and by
modulation of GABAergic and glutamatergic synaptic connections in longer-term conditions [12].
In addition, tDCS has realistic potential for implementation into clinical practice [13], remote supervision
paradigms [14], and into home-based care [15]. Furthermore, tDCS has several practical advantages
that make it compatible with other therapies such as portability, safety, ease of administration, ability to
be delivered during motor activities, and low cost [13]. Although the vast majority of studies in
healthy adults and PD have utilized M1-tDCS, increasing evidence suggests that tDCS delivered to
the cerebellum (c-tDCS) can also significantly improve motor performance [16–18]. However, all of
these studies have been conducted in young and old adults, even though the cerebellum is now
recognized to play a significant role in the pathology of PD [19,20]. With the current PD therapies
affected by numerous limitations, there is heightened need to develop additional treatment options,
including novel treatment modalities.
PD has historically been viewed primarily as a basal ganglia disorder due to the well-known
loss of dopaminergic cells in the substantia nigra pars compacta, which leads to reductions in
striatal dopamine and motor impairments. However, several studies have found altered functional
activity in many other important brain areas, especially in M1 and the cerebellum. Accordingly,
it is assumed that cerebellar pathology contributes to impaired motor function in PD. This provides
a theoretical basis for the investigation of c-tDCS as a potential intervention in the disease [19,20].
Furthermore, several other specific research findings support this rationale: (1) c-tDCS improves motor
performance in young [16,18] and older healthy adults [17] and M1-tDCS improves performance
in these populations [10,21] and in PD [11]; (2) increased cerebellar activity compensates for basal
ganglia dysfunction in PD and cerebellar stimulation may enhance this process [20]; (3) tDCS exerts
remote effects on connected brain regions not stimulated directly and formerly unidentified reciprocal
pathways have been found between the cerebellum and basal ganglia [22]; and (4) tDCS efficacy
scales with age [21] and the level of impairment in motor disorders [23], which is relevant because
the majority of individuals with PD are over the age of 60. Despite these observations, no studies have
examined the effects of c-tDCS on fine motor performance of the hand and arm in PD, although a study
by Workman and colleagues found that c-tDCS could improve balance in PD [24].
The purpose of the study was to determine the effects of c-tDCS on motor performance in PD
while on medications. This was accomplished by having participants perform two motor tasks with
their most affected hand in a Baseline condition and in an Experimental condition. Most importantly,
one group of participants received c-tDCS during performance of the motor tasks in the Experimental
condition, whereas the other group received SHAM stimulation. Thus, this allowed for the examination
of whether c-tDCS applied simultaneous with motor task execution can enhance task performance.
The two motor tasks selected for the study included a visuomotor isometric precision grip task (PGT)
and a rapid arm movement task (AMT). These tasks were chosen because it has been shown that there
is strong cerebellar involvement in the motor control and execution of both tasks [25–28]. Based on
previous c-tDCS studies in young [16,18] and especially old adults [17], it was hypothesized that
c-tDCS would enhance performance in the two motor tasks compared to SHAM stimulation.
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2. Materials and Methods
2.1. Participants
Twenty-two individuals with PD (12 males, 10 females; mean age: 71.3 ± 8.6 years) volunteered
to participate in the study. All participants were diagnosed by a movement disorders neurologist
according to standard clinical diagnostic criteria [29]. Participants were free of any other neurological
disorder, did not have an uncontrolled medical condition, and did not meet exclusion criteria for
non-invasive brain stimulation studies. Twenty of the participants were primarily right-side affected
and right-hand dominant, while two participants were primarily left-side affected and left-hand
dominant. The participants provided written informed consent, the protocol (Number 743597) was
approved by the IRB at the University of Nevada Las Vegas, and the research was conducted according
to the Declaration of Helsinki.
2.2. Experimental Design and Procedures
The study utilized a randomized, double-blind, SHAM-controlled, between-subjects design.
Participants were allocated to either a c-tDCS group (n = 11) or a SHAM stimulation group (n = 11)
and completed a single 2–2.5 h experimental session. All participants initially reported to the lab in
the morning after a 12-h overnight medication withdrawal (practically defined-OFF condition) but
performed the experimental interventions and testing on medications (see below). At the beginning
of the session, participants were familiarized with all experimental procedures. This included visual
demonstrations by one of the investigators of all the motor tasks associated with the study. During this
time, participants were required to demonstrate that they understood the task requirements and
the visual feedback provided by the computer programs during the tasks. Subsequently, they completed
5 familiarization trials of the PGT and 20 familiarization trials of the AMT. After the familiarization,
the following procedures were performed in the order described: (1) participants ingested their PD
medications and sat quietly for one hour to allow the medications to take effect; (2) three maximal
voluntary contractions (MVCs) were completed; (3) the baseline condition was performed and involved
5 trials of the PGT and 20 trials of the AMT; (4) the c-tDCS electrode montage was placed on the head;
(5) the stimulator was turned on for 3 min while participants sat quietly; (6) the experimental condition
was completed and involved 10 trials of the PGT and 4 blocks of 20 trials of the AMT performed
simultaneously with the application of c-tDCS; and (7) the stimulator kept running for any time
remaining in the overall 25 min stimulation period (Figure 1).
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Figure 1. Schematic representation of the experimental protocol that included a familiarization
(5 precision grip task (PGT) trials; 20 arm movement task (AMT) trials), medication ingestion followed
by 1 h of rest, 3 maximal voluntary contraction (MVC) trials, a Baseline condition (5 PGT trials;
20 AMT trials), cerebellar transcranial direct current stimulation (c-tDCS) montage placement, and an
Experimental condition (25 min of either c-tDCS or SHAM stimulation concurrent with 10 PGT trials
and 4 blocks of 20 AMT trials).
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2.3. Experimental Tasks
2.3.1. MVCs
A total of three MVC trials were executed using the same experimental arrangement and hand
posture as in the PGT task. Participants were required to produce maximum force in the shortest
possible time and to hold the maximum for 3–5 s as described in previous studies [30,31]. The MVC
task was used to determine the reference value to compute the target forces for the PGT.
2.3.2. PGT
The experimental setup for the PGT was similar to the arrangement used in previous studies [31,32].
Participants sat in a chair and placed their dominant-primarily affected arm on a table located on
one side of the chair. The forearm was positioned on the table with the wrist in a neutral position,
the shoulder abducted (45◦), the elbow flexed (90◦), and with the hand in a semi-supinated posture.
The PGT required participants to match a sine wave target template that scrolled across a computer
monitor. This was accomplished by producing isometric force using the index finger and thumb
in a precision grip against a custom-made grip manipulandum equipped with force transducers.
Participants were instructed to match their force trace to the target template as accurately as possible
for the duration of each PGT trial. The minimum and maximum values of the sine wave were 5% and
25% of the MVC force, whereas the sine wave frequency was set to 1 Hz. A single PGT trial involved
matching the template for a duration of 30 s followed by 30 s of rest. In the familiarization and in
the Baseline condition, the PGT was performed without concurrent stimulation. In contrast, the PGT
was performed simultaneously with c-tDCS or SHAM stimulation during the Experimental condition.
Finally, note that the stimulator was turned on for 3 min [18] as participants sat quietly prior to the start
of the first PGT trial (Figure 1).
The PGT was selected as a motor task for three interrelated reasons. First, precision grip tasks
have been successfully employed in several M1-tDCS studies [33–35] and a c-tDCS study in young
adults [36]. Furthermore, a study (manuscript in preparation) involving M1-tDCS in PD that was
recently completed in our lab utilized the PGT. All of the aforementioned studies found that tDCS
evokes substantial increase in force accuracy in these precision grip tasks. Thus, there is a high
probability that increases in performance due to c-tDCS can be evoked in the PGT. Second, the precision
grip is a complex, multi-joint functional task that is employed frequently in tasks of daily living;
(3) numerous studies have shown that there is a high level of cerebellar involvement in visuomotor
tracking tasks [28]. In addition, the PGT is relevant to PD for at least two important reasons. First,
impairments in force generation and relaxation are well-characterized in PD in isometric precision
grip tasks and highly dependent on basal ganglia function [37–39]. Second, the PGT involves strict
force accuracy of force production requirements and force accuracy is usually lower in PD compared
to age-matched controls [40].
2.3.3. AMT
The AMT was performed in a nearly identical manner and experimental arrangement as in a
previous study in young and old adults [41]. Briefly, participants executed the AMT with the dominant,
primarily affected arm on a digitizer tablet with a digitizer pen while receiving visual feedback of
the task on a computer monitor linked to the tablet. Participants were instructed to perform the AMT as
fast and as accurately as possible using a single movement that required elbow extension and shoulder
flexion. The movements were performed from a home circle to a very small target circle of 0.5 cm in
diameter located at a relatively long distance (20 cm) away from the participant. Once the pen was
stationary and the participants had assumed the correct starting posture, a “GO” signal was given by a
customized script that controlled the experiment. Participants then performed the movement at their
convenience (no reaction time component). Furthermore, the script did not provide participants with
visual feedback of the cursor movement (trajectory) during the trial, but they receive visual feedback
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of their endpoint performance relative to the target, which was provided 1 s after each trial for a
duration of 3 s. Participants were directed to endeavor to minimize endpoint error distance on each
successive trial. The AMT was performed without concurrent stimulation in the familiarization and in
the Baseline condition. In contrast, the AMT was performed simultaneously with c-tDCS or SHAM
stimulation during the Experimental condition. Finally, note that the stimulator was kept on after
completion of the last AMT trial block (usually a time frame of 1–3 min) until the 25 min stimulation
period elapsed (Figure 1).
The AMT was selected as a motor task due to the strong cerebellar involvement in several related
aspects of movement control related to this task [25–28]. First, it is an unconstrained, multi-joint
movement entailing the prediction, regulation, and exploitation of joint interaction torques. Second,
it involves the precise timing of agonist and antagonist muscle bursts to attain endpoint accuracy.
Third, trial-to-trial performance in the AMT is highly dependent on the ability to detect and correct for
endpoint errors on successive trials. In addition, the AMT is relevant to PD for several reasons. First,
multi-joint arm movement control impairments are well-characterized in PD [42]. Second, movement
velocity is one aspect of the AMT and this would reflect on the ability of c-tDCS to address bradykinesia
in PD. Third, the AMT involves strict endpoint accuracy requirements and movement accuracy is
usually lower in PD compared to age-matched controls.
2.3.4. c-tDCS
A NeuroConn DC Stimulator Plus/MR delivered tDCS through two rubber electrodes (5 cm× 5 cm)
that were encased in saline soaked sponges and secured in place by two rubber straps. Anodal c-tDCS
was applied over the cerebellum ipsilateral to the primarily affected hand with the anode 3 cm lateral
to the inion and the cathode over the ipsilateral buccinator muscle [43]. The stimulation duration was
25 min and the current strength was set to 2 mA. These c-tDCS parameters produced substantial and
immediate increases in motor performance in young and old adults in prior studies [16–18]. Note that
the stimulator was turned on for 3 min while participants sat quietly before performing the first PGT
trial [18]. In the SHAM stimulation condition, the current was ramped up and down over 30 s, which is
the most widely utilized SHAM stimulation protocol in the literature [44]. The tDCS device settings
were programmed by an investigator who did not partake in either the data collection sessions or
the data analysis portion of the project. Similarly, the researchers who conducted the experiments and
analyzed the data were blind to the experimental condition in each experiment.
2.4. Data Analysis
The dependent variables were the force error in the PGT and the endpoint error and movement
velocity in the AMT. All PGT data were collected in Spike2 software (Cambridge Electronic Design,
Cambridge, UK) and analyzed in custom-written Spike2 scripts. AMT data were collected with
Movalyzer software (Neuroscript, Tempe, AZ, USA) and analyzed using custom-written Matlab
code [41]. Force error was computed as the average error in force over each 30 s trial of the PGT.
Specifically, the difference (absolute value) between the force produced and the target force associated
with the template was calculated at each sampling point for the entire 30 s trial and then the average
of these values was taken. Thus, this average represented the average force error for one 30 s
trial. The grand averages of the trials were then taken for the Baseline and Experimental conditions.
Accordingly, the average of the 5 trials in the Baseline condition and the average of the 10 trials
in the Experimental condition were taken as the final force error values for analysis. For the AMT,
the endpoint error was calculated using the Pythagorean Theorem as in previous studies [41,45]. Thus,
the x, y coordinates of the final endpoint of the pen and the center of target were used to determine
the shortest distance between these two points. Movement velocity was calculated and quantified as
the average velocity according to previous methods [41]. The average of the 20 trials in the Baseline
condition and the average of the 80 trials (4 blocks of 20 trials) in the Experimental condition were
taken as the final endpoint error and average velocity values for analysis.
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2.5. Statistical Analysis
The UPDRS scores in the OFF medication state and the levodopa equivalent daily dose (LEDD)
between groups were compared with unpaired t-tests, whereas Hoehn and Yahr scores were evaluated
with a Chi Square Test. Two-way ANOVAs (2 group (c-tDCS, SHAM) × 2 condition (Baseline,
Experimental)) with repeated measures on condition were used to compare force error in the PGT as
well as endpoint error and movement velocity in the AMT, respectively. Post-hoc tests (Fisher LSD)
were used to locate differences among pairs of means when appropriate. The significance level was set
at α < 0.05 and data are indicated as means ± standard errors in the figures.
3. Results
The UPDRS scores were 24.7 ± 5.7 for the c-tDCS group and 28.4 ± 12.1 for the SHAM group
and the difference between groups was not statistically significant (p = 0.377). LEDD was also similar
between the two groups (c-tDCS group = 584.8 ± 516.2, SHAM group 468.5 ± 193.7; p = 0.63). The Hohn
and Yahr scores were 2.3 ± 0.65 for the c-tDCS group and 2.0 ± 0.63 for the SHAM group and the Chi
Square Test was not significant (p = 0.310). Representative PGT data for the Baseline and Experimental
conditions for one participant are shown in Figure 2. For the two-way ANOVAs, all of the assumptions
were met, and no corrections were made. In regard to the assessment of normality of the data,
the Shapiro–Wilk test was used due to the relatively small sample size. None of the Shapiro–Wilk tests
were significant for the force error or movement velocity. Furthermore, the Shapiro–Wilk test was
only significant (0.046) for the distribution of data for the SHAM group in the Experimental condition
and not for the other three sets of data (factor levels). Therefore, we decided to perform parametric
statistics for not only force error and movement velocity, but also for endpoint error.
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Figure 2. Representative precision grip task (PGT) trials illustrate the significant decline in force error
that occurred bet een the two conditions. For this representative participant, the reduction in force error
was 4.22 N between these two trials. (A) The force time profile for a single trial performed in the Baseline
condition. (B) The force time profile for a single trial performed in the Experimental condition.
3.1. PGT
The group× condition interaction (F(1,20) = 0.729, p = 0.403, η2 = 0.035) and the main effect for group
(F(1,20) = 0.031, p = 0.861, η2 = 0.002) were not statistically significant for force error in the PGT. However,
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there was a significant main effect for condition (F(1,20) = 9.932, p = 0.005, η2 = 0.332), which indicated that
force error was significantly lower in the Experimental condition compared to the Baseline condition
(Figure 3A). Using the means and standard deviations from these analyses and the “repeated measures
analysis” module on PASS 2020 (NCSS, LLC. Kaysville, UT, USA, www.ncss.com/software/pass), it was
determined that 347 participants per group (336 additional participants per group) would be needed
to achieve sufficient power to find a statistically significant interaction for the group × condition
interaction for the PGT.
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Figure 3. Forc er or in the precision grip task t e cerebel ar transcranial direct current
stimulation (c-tD S) (closed squares) and SHAM groups (open quares) in the Ba eline and Experiment l
conditions. (A) The force error was not significantly different between the c-tDCS and SHAM groups
(p = 0.861), but it was significantly lower in the Experimental condition compared to the Baseline
condition (p = 0.005). * indicates a significant difference between the Baseline and Experimental
conditions. (B) Individual PGT participant data corresponding to the data in Panel (A) for the 11
participants in the c-tDCS group and 11 participants in the SHAM group. (C) For illustrative purposes,
the individual PGT trials corresponding to the average data presented in Panel (A) are depicted. It can
be seen that there is no trend for PGT performance to improve with trial number to a greater extent in
the c-tDCS group compared with the SHAM group due to the accumulating stimulation time.
3.2. AMT
For endpoint error in the AMT, the group × condition interaction was not statistically significant
(F(1,20) = 4.05, p = 0.058, η2 = 0.168). The main effect for group (F(1,20) = 0.349, p = 0.561, η2 = 0.017) and
main effect for condition (F(1,20) = 2.092, p = 0.164, η2 = 0.095) were both no -statistically significant
(Figure 4A).
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Figure 4. Endpoint error in the arm movement task (AMT) for the cerebellar transcranial direct
current stimulation (c-tDCS) (closed squares) and SHAM groups (open squares) in the Baseline and
Experimental conditions. (A) The endpoint error was not significantly different between c-tDCS and
SHAM groups (p = 0.561) or for the Baseline and Experimental conditions (p = 0.164). (B) Individual
endpoint error data c rresponding to the data in Panel (A) for the 11 participants in the c-tDCS group
and 11 participants in the SHAM group. (C) For illustrative purposes, the individual AMT trial blocks
corresponding to the average data presented in Panel (A) are depicted. It can be seen that there is no
trend for endpoint error to improve with trial block number to a greater extent in the c-tDCS group
compared with the SHAM group due to the accumulating stimulation time.
Similarly, for average movement velocity in the AMT, the group × condition interaction was
not statistically significant (F(1,20) = 0.072, p = 0.791, η2 = 0.004). Finally, the main effect for group
(F(1,20) = 0.000, p = 0.994, η2 = 0.000) and main effect for condition (F(1,20) = 2.443, p = 0.134, η2 = 0.109)
were both non-statistically significant (Figure 5A).
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Figure 5. Average velocity for the arm move ent task (AMT) for the cerebellar transcranial direct
current stimulation (c-tDCS) (closed squares) and SHAM groups (open squares) in the Baseline and
Experimental conditions. (A) The movement velocity was not significantly different between c-tDCS
and SHAM groups (p = 0.994) or for the Baseline and Experimental conditions (p = 0.134). (B) Individual
average velocity data corresponding to the data in Panel (A) for the 11 participants in the c-tDCS group
and 11 participants in the SHAM group. (C) For illustrative purposes, the individual AMT trial blocks
corresponding to the average data presented in Panel (A) are depicted. It can be seen that there is no
trend for movement velocity to improve with trial block number to a greater extent in the c-tDCS group
compared with the SHAM group du to the accumulating stimul tion time.
4. Discussion
The purpose was to determine the effects of c-tDCS on motor performance in PD while participants
were on medications. There were two main findings. First, c-tDCS did not significantly reduce force
error in a complex, visuomotor precision grip task to a greater extent than SHAM stimulation. Second,
c-tDCS did not significantly improve endpoint accuracy in a rapid, goal-directed arm movement task
in PD. Collectively, these results indicate that a single session of c-tDCS does not elicit improvements
in motor performance in han and arm tasks in PD.
4.1. Influence of Acute c-tDCS Application on Motor Performance in PD
c-tDCS administered simultaneously with the performance of motor tasks has been shown to
elicit a ute enhancements in motor performance in young and older adults. The capacity of tDCS
to impact motor performance in older adults is particularly noteworthy for several reasons. First,
accumulating evidence indicates that the cerebellum could be the predominant brain structure involved
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in the well-known movement impairments displayed by older adults [46]. Second, the majority of
individuals with PD are older adults as the average age at initial diagnosis 60, which implies that
at least some of the mechanisms of action of c-tDCS in old adults could generalize to PD. Third,
the cerebellum is implicated in some of the motor control deficits exhibited by individuals with PD
in arm movement tasks [42]. Specifically, cerebellar involvement is critical in multi-joint movement
regulation related to factors such as the prediction and utilization, as well as the compensation for joint
interaction torques [47,48], the modulation of antagonistic muscle interactions [26], and error detection
in goal-directed tasks [27].
Based on these lines of reasoning and dysfunction of the cerebellum in PD, the present study
examined the influence of c-tDCS on the performance of two motor tasks (PGT, AMT) in PD. The original
hypothesis was that force error in the PGT and endpoint error in the AMT would be lower in the c-tDCS
group compared with the SHAM group. Contrary to these expectations, the reduction in force error in
the PGT from the Baseline session to the Experimental session was nearly identical between the two
groups. For the AMT, the reduction in endpoint error was greater in the tDCS group, but this difference
did not reach statistical significance due to the high degree of performance variability present in both
groups of participants in this difficult arm movement task. Finally, endpoint error performance could
not have been influenced by the velocity at which the AMT was performed as average movement
velocity was similar between groups and between the Baseline and Experimental conditions.
Taken together, the results are not consistent with the majority of prior c-tDCS studies in young
and old adults that also employed pinch grip and arm movement tasks [16–18,36]. For example,
a recent study in our laboratory [18] found that motor skill acquisition was enhanced in a difficult
overhand throwing task in young adults, when c-tDCS was given simultaneously with task practice.
Most importantly, most of the effects of c-tDCS on motor skill were evident within the first block
of 10 practice trials, but they continued at a decreasing rate until reaching the lowest point over
the course of 20 further practice trials. The current results also differ from the augmentations in
motor performance attained in the preponderance of M1-tDCS studies in PD [11,49,50]. Conversely,
Steiner et al. found that c-tDCS did not increase the magnitude of motor learning attained by young
adults in a whole-body dynamic balance task [51]. Furthermore, our results are highly compatible
with a very similar c-tDCS study conducted in dystonia [52]. Specifically, Sadnicka et al. reported
that one session of c-tDCS failed to improve clinical measures of handwriting skill and proficiency
in dystonia [52]. These observations are applicable to the present study because dystonia is also
predominantly a motor disorder of the basal ganglia, which, like PD, is associated with cerebellar
dysfunction that negatively impacts movement control. Thus, c-tDCS may be ineffective at reducing
motor impairments in these two particular movement disorders, at least when administered in a single,
25 min session.
4.2. Possible Factors Responsible for the Lack Ability of c-tDCS to Improve Motor Performance in PD
The conflicting results of the current study relative to the vast majority of previous c-tDCS studies
in young and older adults and M1-tDCS studies in PD suggest that care must be taken in assuming
that c-tDCS always improves motor function or that findings obtained in healthy adults can always be
extended to PD. Accordingly, there are several possible explanations that could explain the lack of
ability of c-tDCS to enhance motor performance in the present task conditions.
The most likely possibility is that administration of a single c-tDCS session is not adequate to
substantially improve movement accuracy. Thus, repeated stimulation sessions over a time periods
ranging from 3–10 days may be needed to induce noticeable effects in PD. Accordingly, this line of
reasoning was identified as the most probable reason why c-tDCS did not improve clinical writing
scales in dystonia [52]. Specifically, a strong case was made that it is highly doubtful that one c-tDCS
session would be potent enough to supersede the long-term pathological changes associated with
motor deficits in the disorder. Therefore, it is easily conceivable that this phenomenon was at least
partially responsible for the current pattern of results in PD. These interpretations are supported by
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evidence from a series of M1-tDCS studies [33,34,53,54] as well as a prominent c-tDCS study [36],
in motor learning effects accumulated over a timescale of 3–5 days. However, only one of these
investigations found that the effects of tDCS on motor performance were not also significant on the first
day of practice and stimulation. In addition, the overwhelming balance of tDCS studies in both healthy
adults and in PD have only involved a single stimulation session and review articles [10,11,49,50]
appear to show that tDCS yielded positive results in 75–80% of these acute studies. Accordingly, it is
not obligatory that multiple daily stimulation sessions are required to observe enhancements in motor
function due to c-tDCS.
Another explanation for the current findings is that the several cerebellar-thalamic-cortical
pathways that ultimately influence the corticospinal output cells in M1 display maladaptive changes
in PD. Similarly, the recently identified bi-directional pathways [22] between cerebellum and basal
ganglia almost certainly exhibit similar alterations. Thus, administration of c-tDCS in PD may not lead
to the same modulation of behavioral outcomes in PD compared to those elicited in healthy adults.
Accordingly, a number of transcranial magnetic stimulation (TMS) studies have demonstrated that
several cerebellar pathways provide inputs onto interneuronal facilitatory and inhibitory circuits within
M1 [55–57]. Therefore, the extensive dysfunction in all of the motor loops interconnecting the cerebellum,
M1, and basal ganglia could potentially have contributed to the absence of improvements in motor
performance found in the present study in PD.
A final possibility is that c-tDCS parameters such as the electrode montage (electrode sizes,
anode location, cathode location), the stimulation duration, and the current strength were not the ideal.
Accordingly, some previous investigations have obtained significant results with stimulation parameters
that differ in a few of these methodological aspects, at least in other populations and experimental
contexts [58]. Although these assertions are conceivable, it seems very improbable as the exact same
c-tDCS parameters were effective in enhancing motor skill acquisition in a previous study from our
laboratory [18] in young adults and in a series of investigations by another research group in both
young and older adults [16,17,59,60]. Nonetheless, a recent study by Workman and colleagues (2020)
compared the effects of four c-tDCS electrode montage (unilateral, bilateral) and current intensity (2 mA,
4 mA) combinations on balance performance in PD [24]. The main finding was that only the bilateral
montage that used a 4 mA current intensity improved balance scores in PD. Thus, it is possible that
this montage and current intensity combination may be more effective for the improvement of motor
performance in PD compared to the unilateral montage and 2 mA current intensity used in the present
study. Future c-tDCS studies involving fine motor control tasks of the hand and arm in PD should
investigate this possibility. Furthermore, it is unlikely that the two motor tasks used in current study
are viable explanations for the lack of c-tDCS effects because a large number of studies have found
that these tasks are highly amenable to c-tDCS and M1-tDCS and are characterized by high degrees of
cerebellar involvement [23,33,34,36,53,61,62]. Nevertheless, all of the aforementioned possibilities will
need to be investigated in additional studies that can simultaneously address the influence of c-tDCS
applied over multiple days on the physiological mechanisms underlying behavioral outcomes in PD.
5. Conclusions
In summary, the findings of the study indicated that a single session of c-tDCS does not improve
motor performance in precision grip and arm movement tasks in PD. Thus, future investigations
should determine the influence of repeated administration of c-tDCS over multiple days to further
examine the utility of c-tDCS as a modality to enhance motor abilities in PD.
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